Hints and tips:
...The markets of Zürich are filled with promotional editions of this humble pocket knife, emblazoned with the logos of many of Switzerland’s peaceful 20th-century corporate giants, from Brown Boveri to Ciba-Geigy...
...Founded by the Sandoz family, the business merged with Ciba-Geigy to create Novartis in 1996....
...Sandoz, which last year admitted to price fixing in the US, was one of the components of the merger with Ciba-Geigy that created Novartis in 1996....
...The bourgeois boy from Basel (his parents worked for the Ciba-Geigy pharmaceutical company) left home at 14 to enter a tennis academy. “I cried when I was away....
...Novartis was created in 1996 when Mr Vasella merged Ciba-Geigy and Sandoz. Under Mr Jimenez’s leadership, Novartis has been cautious about mergers and acquisitions....
...Rather, it is part of the mixed legacy of Daniel Vasella, the former Novartis patriarch who founded the company in 1996 by merging Ciba-Geigy with Sandoz....
...Back then they were thick with advertisements from Ciba-Geigy, Hoffmann-La Roche, Sandoz and the other manufacturers from the Rhine’s Clinicon Valley....
...Its roots go back to three Swiss pharmaceutical companies — Ciba, Geigy and Sandoz — and the British chemical giant Imperial Chemical Industries....
...Mr Jimenez took on the top job in 2010 after Daniel Vasella, who helped create the Basel-based pharma group by merging two Swiss chemicals groups, Sandoz and Ciba-Geigy, stepped down as chief executive....
...Alza had to be bailed out by Ciba-Geigy, a Swiss chemical company and forerunner of today’s Novartis, but gradually found success with products including a patch to help people quit smoking and extended-release...
...Mr Vasella was the driving force at Novartis after its creation from the 1996 merger of Sandoz with Ciba-Geigy....
...cash and about SFr2.2m in shares In addition, Mr Vasella will hold the title of honorary chairman in recognition of his role in creating Novartis, which was formed through the 1996 merger of Sandoz with Ciba-Geigy...
...Mr Vasella has longstanding connections with the US, having worked at Sandoz’s American arm in the years before the merger with Ciba-Geigy....
...The board awarded him the title in recognition of his unique role in creating Novartis, a product of the 1996 merger of Ciba-Geigy and Sandoz, and then running the group for 17 years....
...He argued that Novartis – created by the 1996 merger of Sandoz with Ciba-Geigy overseen by Mr Vassella – had generated substantial returns for shareholders, had brought great medical gains and access to...
...Having been present at the creation – he was chief executive of Sandoz when it merged with Ciba-Geigy in 1996 to create Europe’s biggest pharma group by sales – and its driving force ever since, i§t is clearly...
...After his doctorate he joined Sandoz, which merged with Ciba Geigy to create Novartis in 1996....
...He moved into industry in 1985 at Ciba-Geigy as a scientist, and then to Glaxo in 1989. He left Glaxo, where he was UK research director, to join PowderJect in 2001....
...Novartis, originally created through the merger of Sandoz and Ciba-Geigy in 1996, has since continued to expand through acquisitions in recent years, leaving it with many smaller units around the world....
...are only about Dr Vasella’s age of 57, he has already been chief executive for 14 years and held the combined role of chairman at Novartis for 11 years following its formation by the merger of Sandoz and Ciba-Geigy...
...Dr Vasella is one of the pharmaceutical industries’ longest-serving chief executives and the architect of Novartis’s transformation into a world-leading healthcare group following the merger of Ciba-Geigy...
...Dr Vasella is one of the pharmaceutical industries’ longest-serving chief executives and the architect of the transformation of Novartis into a world-leading healthcare group following the merger of Ciba-Geigy...
...In the decade after the second world war, Ciba-Geigy introduced the stimulant methylphenidate, branded as Ritalin, initially to treat psychosis....
...But Daniel Vasella (pictured), chairman and chief executive of Novartis, who had an active role in the Swiss company’s creation through the merger of Ciba-Geigy and Sandoz in 1996, as well as several big...
...Daniel Vasella, although only 53, has become the doyen of the sector, a decade after he was named the first chief executive of Novartis, the Swiss group formed by the merger of Sandoz and Ciba-Geigy, in...
International Edition